| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.24B | 4.42B | 2.77B | 2.41B | 685.25M | 40.65K |
| Gross Profit | 102.25M | 69.28M | 88.14M | 57.97M | 21.07M | -89.35K |
| EBITDA | 114.40M | 116.63M | 233.92M | 72.67M | 11.32M | -1.62M |
| Net Income | 28.23M | 38.39M | 154.35M | 66.67M | 10.88M | -6.05M |
Balance Sheet | ||||||
| Total Assets | 2.57B | 2.21B | 2.02B | 1.61B | 168.83M | 1.57M |
| Cash, Cash Equivalents and Short-Term Investments | 796.00K | 1.12M | 19.56M | 55.07M | 3.91M | 577.79K |
| Total Debt | 397.56M | 264.12M | 73.77M | 284.75M | 287.20M | 285.93M |
| Total Liabilities | 859.29M | 513.01M | 845.41M | 855.57M | 459.91M | 303.53M |
| Stockholders Equity | 1.71B | 1.70B | 1.17B | 754.09M | -291.08M | -301.96M |
Cash Flow | ||||||
| Free Cash Flow | -360.60M | -1.08B | -110.56M | 69.46M | 3.01M | -1.45M |
| Operating Cash Flow | -360.55M | -887.42M | -95.85M | 470.03M | 3.09M | -1.45M |
| Investing Cash Flow | 239.99M | 191.96M | 16.48M | -1.40B | -43.00K | 0.00 |
| Financing Cash Flow | 119.67M | 677.02M | 43.86M | 978.56M | 815.68K | 1.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | ₹4.17B | 161.27 | ― | ― | 14.91% | -73.10% | |
63 Neutral | ₹1.61B | 6.70 | ― | 2.79% | 9.72% | -57.95% | |
55 Neutral | $13.29B | 17.42 | 10.03% | 0.93% | 7.13% | -12.93% | |
54 Neutral | ₹1.36B | 32.19 | ― | ― | 13.81% | -73.78% | |
46 Neutral | ₹1.37B | -0.64 | ― | ― | ― | ― | |
46 Neutral | ₹1.33B | 13.10 | ― | ― | -8.31% | -40.98% |
Integra Essentia Limited’s board has approved its unaudited standalone and consolidated financial results for the quarter ended 31 December 2025, which have been reviewed by its statutory auditors in line with securities market disclosure requirements. The board has also cleared a plan to raise up to Rs 100 crore through a rights issue of fully paid equity shares with a face value of Re 1 each to eligible existing shareholders, subject to regulatory and statutory approvals, marking a fresh round of capital-raising that could strengthen the company’s balance sheet and support future growth initiatives.